Side-by-side comparison of AI visibility scores, market position, and capabilities
LVMH €10.58B jewelry 2024 ($11.04B, -3%); Fifth Ave flagship record sales; high jewelry revenue 4x since LVMH acquisition; iconic luxury jeweler
Tiffany & Co was founded in 1837 in New York City by Charles Lewis Tiffany, establishing itself as America's premier jeweler through a combination of exceptional craftsmanship, design innovation, and aspirational branding. The company introduced the iconic Tiffany Blue color and the Tiffany Setting engagement ring solitaire — still the world's most recognized ring design — and built a retail presence anchored by its flagship Fifth Avenue store, one of the most famous retail addresses in the world. In 2021, LVMH completed its $15.8B acquisition of Tiffany, the largest luxury deal in history.\n\nTiffany & Co's product portfolio spans engagement and wedding jewelry, high jewelry collections, silver accessories, watches, leather goods, and fragrances. Key design families include the Tiffany T, HardWear, Return to Tiffany, and the Blue Book high jewelry collections released annually. Under LVMH's ownership, Tiffany has undergone a significant brand elevation strategy — renovating the Fifth Avenue flagship (dubbed "The Landmark"), expanding high jewelry revenue, and refreshing its marketing positioning to attract younger affluent consumers globally.\n\nTiffany & Co is part of LVMH's Watches & Jewelry division, which reported €10.58B in revenue in 2024. Since the LVMH acquisition, Tiffany's Fifth Avenue flagship has achieved record sales, and high jewelry revenue has quadrupled, reflecting successful repositioning toward the ultra-high-net-worth customer segment. The brand's combination of American heritage, iconic design vocabulary, and LVMH's global distribution and marketing infrastructure makes it one of the most strategically valuable jewelry brands in the world.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.